Nataša Todorović‐Raković

Author

Also Known As

N Todorovic-Rakovic, N Todorović-Raković, N. TODOROVIĆ‐RAKOVIĆ, N. Todorovic-Rakovic, N. Todorović-Raković, Natasa Todorovic-Rakovic, NatašA Todorovic-Raković, Nataša Todorović Raković, Nataša Todorović-Raković, Nataša Todorović‐Raković

Publications

764

Citations

H-Index

Concepts

All Affiliations

Oncology Institute of Vojvodina

About

Nataša Todorović‐Raković is an author at Oncology Institute of Vojvodina specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	293
2	Pathology	7	7	280
3	Cell Biology	3	3	57
4	Immunology	3	3	74
5	Cancer Cell Biology	1	1	13

Nataša Todorović‐Raković

Publications

368

Citations

H-Index

Page 1

	Year	Citations
Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progression Vesna Ivanović, Nataša Todorović‐Raković, Miroslav Demajo, European Journal of Cancer Advanced Breast CancerBreast OncologyDisease ProgressionPlasma LevelsMedicine	2003	138
Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer Jelena Milovanović, Nataša Todorović‐Raković, Marko Radulović Cytokine Breast OncologyHormone-dependent Breast CancerMedicineInterleukin-8 Serum LevelsImmunology	2018	30
The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients. Jelena Milovanović, Nataša Todorović‐Raković, Zaki Abu Rabi PubMed	2014	29
Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer Nataša Todorović‐Raković, Danica Jovanović, Zora Nešković‐Konstantinović, Experimental and Molecular Pathology Metastatic Breast CancerBreast OncologyMedicinePrognostic ValuePathology	2007	27
The prognostic significance of serum interferon-gamma (IFN-γ) in hormonally dependent breast cancer Nataša Todorović‐Raković, Jelena Milovanović, John Greenman, Cytokine Prognostic BiomarkersBreast OncologyEndocrine OncologyMedicineImmunology	2022	26
Plasma TGF-β1-related survival of postmenopausal metastatic breast cancer patients Dragica Nikolić‐Vukosavljević, Nataša Todorović‐Raković, Miroslav Demajo, Clinical & Experimental Metastasis Breast OncologyPlasma Tgf-β1-related SurvivalMedicinePathologyBreast Cancer	2005	24
Comparison between immunohistochemistry and chromogenic <i>in situ</i> hybridization in assessing HER‐2 status in breast cancer Nataša Todorović‐Raković, Danica Jovanović, Zora Nešković‐Konstantinović, Pathology International	2005	20
C-myc as a predictive marker for chemotherapy in metastatic breast cancer Nataša Todorović‐Raković, Zora Nešković‐Konstantinović, Dragica Nikolić‐Vukosavljević Clinical and Experimental Medicine Metastatic Breast CancerBreast OncologyMedicineImmunologyPathology	2011	18
Size and Shape Filtering of Malignant Cell Clusters within Breast Tumors Identifies Scattered Individual Epithelial Cells as the Most Valuable Histomorphological Clue in the Prognosis of Distant Metastasis Risk Velicko Vranes, Nemanja Rajković, Xingyu Li, Cancers Breast OncologyCancer ManagementPathologyTumor BiologyOncology	2019	17
Markers of progression and invasion in short term follow up of untreated breast cancer patients Zaki Abu Rabi, Nataša Todorović‐Raković, Tijana Vujasinović, Cancer Biomarkers	2015	15

Page 1